Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
Cancer Therapies02:49

Cancer Therapies

7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Methods of Documentation II: POMR01:26

Methods of Documentation II: POMR

1.1K
The Problem-Oriented Medical Record (POMR) revolutionized medical record-keeping by introducing a systematic approach focusing on the patient's problems rather than merely listing symptoms. Dr. Lawrence Weed's introduction of this method in the 1960s marked a significant advancement in medical documentation. The POMR framework consists of four key components: the database, problem list, plan of care, and progress notes.
1.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ethical Implementation of Organ Donation Following Medical Assistance in Dying: Recommendations of the Ethics Committee of the Transplantation Society.

Transplantation·2026
Same author

Evaluation of radiotherapy dose and survival outcomes for teenagers, and young adults with nasopharyngeal carcinoma in UK & Ireland.

Oral oncology·2026
Same author

Clarifying the Donation After Circulatory Death Process: Addressing Misunderstandings, Correcting Misinformation, and Building Trust Through Education.

Transplantation·2026
Same author

Modified brain injury guidelines in a regional Australian setting indicate significant resource savings but also safety concerns.

Emergency medicine journal : EMJ·2026
Same author

Expanding the Boundaries of Kidney Paired Donation: A Structured Review of Compatible Pair Participation.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
Same author

Upfront management of brain metastases in oncogene‑addicted NSCLC - An EORTC survey.

Lung cancer (Amsterdam, Netherlands)·2026

Related Experiment Video

Updated: Sep 10, 2025

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.5K

Integrating Electronic Patient-Reported Outcome Measures (ePROMs) into Personalised Follow-up for Patients after

Thitikorn Nuamek1, Peggy Adwoa Nuamah Kwateng1,2, Amelia Payne1

  • 1Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK.

Technical Innovations & Patient Support in Radiation Oncology
|August 22, 2025
PubMed
Summary

Integrating electronic patient-reported outcome measures (ePROMs) into personalized follow-up is feasible and well-accepted by cancer patients. This approach enhances remote monitoring and timely intervention for side effects after radiotherapy.

Keywords:
Electronic Patient-Reported Outcome MeasuresHead and Neck CancerLung CancerPersonalised Follow-upRadiotherapy

More Related Videos

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.2K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K

Related Experiment Videos

Last Updated: Sep 10, 2025

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant
05:18

Author Spotlight: Improving Radiation Therapy Access with Radiation Planning Assistant

Published on: October 6, 2023

1.5K
Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction
09:44

Pretargeted Radioimmunotherapy Based on the Inverse Electron Demand Diels-Alder Reaction

Published on: January 29, 2019

10.2K
Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
07:13

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform

Published on: April 12, 2021

4.5K

Area of Science:

  • Oncology
  • Digital Health
  • Patient Monitoring

Background:

  • There is a critical gap in patient monitoring between radiotherapy completion and follow-up appointments, a period where severe side effects can emerge.
  • Personalized follow-up strategies, utilizing electronic patient-reported outcome measures (ePROMs), can tailor healthcare and enable early intervention.
  • ePROMs facilitate remote monitoring, allowing for the timely identification of patients requiring immediate clinical attention.

Purpose of the Study:

  • To evaluate the feasibility and patient acceptance of integrating ePROMs into the personalized follow-up care pathway for patients undergoing radiotherapy.
  • To assess the effectiveness of ePROMs in capturing patient-reported symptoms and facilitating timely clinical response.

Main Methods:

  • A feasibility study involving patients with lung or head and neck cancer undergoing radiotherapy.
  • ePROMs questionnaires (EQ-5D-5L and cancer-specific items) were administered at multiple timepoints, including pre-treatment, during, and post-radiotherapy.
  • Automated advice was provided based on responses, with severe symptoms (Grade 2+) escalated to clinicians; patient feedback was gathered via interviews.

Main Results:

  • Nineteen patients (10 lung, 9 head and neck) were recruited; ePROMs completion rates averaged 69.1% across all timepoints.
  • Three patients reported Grade 3+ symptoms on five occasions, leading to clinical escalation.
  • Fourteen patients interviewed found ePROMs easy to complete, time-efficient, and supportive, indicating high acceptability.

Conclusions:

  • The integration of ePROMs into personalized radiotherapy follow-up is both feasible and highly acceptable to patients.
  • ePROMs offer valuable insights into patient symptom experience during and after radiotherapy, underscoring the importance of tailored follow-up care.
  • This digital health approach supports enhanced patient monitoring and timely management of treatment-related side effects.